24 phenotypes from 4 alleles in 6 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Sgcatm1Eeng/Sgcatm1Eeng involves: 129S/SvEv * 129X1/SvJ	impaired skeletal muscle contractility	J:83034
Sgcatm1Isrd/Sgcatm1Isrd involves: 129S2/SvPas * BALB/c * C57BL/6	normal muscle phenotype	J:133929
Sgcatm1Kcam/Sgcatm1Kcam involves: 129S1/Sv * 129X1/SvJ	abnormal circulating pyruvate kinase level	J:49992
	abnormal muscle contractility	J:49992
	abnormal muscle fiber morphology	J:49992
	abnormal sarcolemma morphology	J:49992
	abnormal skeletal muscle fiber morphology	J:133929
	calcified muscle	J:49992
	cardiac fibrosis	J:177563
	cardiac muscle necrosis	J:177563
	cardiomyopathy	J:177563
	centrally nucleated skeletal muscle fibers	J:49992
	dystrophic muscle	J:49992
	heart inflammation	J:177563
	increased circulating creatine kinase level	J:49992, J:130252
	increased extensor digitorum longus weight	J:49992
	increased soleus weight	J:49992
	normal muscle phenotype	J:177563
Sgcatm2Kcam/Sgcatm2Kcam B6.129S6-Sgcatm2Kcam/J	abnormal muscle physiology	J:250485
	abnormal skeletal muscle morphology	J:250485
	decreased grip strength	J:250485
	decreased pulmonary respiratory rate	J:250485
	dystrophic muscle	J:250485
	increased circulating creatine kinase level	J:250485
	skeletal muscle fibrosis	J:250485
Sgcatm2Kcam/Sgcatm2Kcam either: (129S6/SvEvTac-Sgcatm2Kcam) or (involves: 129S6/SvEvTac * C57BL/6J)	abnormal muscle contractility	J:130252
	abnormal muscle fiber morphology	J:130252
	abnormal sarcolemma morphology	J:130252
	calcified muscle	J:130252
	dystrophic muscle	J:130252
	increased circulating creatine kinase level	J:130252
	increased muscle weight	J:130252
Sgcatm2Kcam/Sgcatm2Kcam Tg(Ckmm-cre)5Khn/0 either: (involves: 129S4/SvJae * 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6J * FVB)	normal homeostasis/metabolism phenotype	J:130252
	normal muscle phenotype	J:130252